159 related articles for article (PubMed ID: 18488153)
21. Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.
Noonan K; Tong KM; Laskin J; Melosky B; Sun S; Murray N; Ho C
Lung Cancer; 2014 Dec; 86(3):344-9. PubMed ID: 25439436
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy uptake in non-small cell lung cancer.
Younis T; Al-Fayea T; Virik K; Morzycki W; Saint-Jacques N
J Thorac Oncol; 2008 Nov; 3(11):1272-8. PubMed ID: 18978562
[TBL] [Abstract][Full Text] [Related]
23. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
24. A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.
Perry MC; Kohman LJ; Bonner JA; Gu L; Wang X; Vokes EE; Green MR
Clin Lung Cancer; 2007 Jan; 8(4):268-72. PubMed ID: 17311692
[TBL] [Abstract][Full Text] [Related]
25. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung Cancer.
Dawe DE; Pond GR; Ellis PM
Clin Lung Cancer; 2016 Nov; 17(6):563-572.e2. PubMed ID: 27374398
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
28. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
Xu YP; Li B; Xu XL; Mao WM
Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
[TBL] [Abstract][Full Text] [Related]
31. Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma.
Aly A; Johnson C; Doleh Y; Shenolikar R; Botteman MF; Hussain A
J Comp Eff Res; 2020 Sep; 9(13):945-957. PubMed ID: 32964721
[No Abstract] [Full Text] [Related]
32. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study.
Liu M; Cai X; Yu W; Lv C; Fu X
Oncotarget; 2015 Dec; 6(42):44963-70. PubMed ID: 26517681
[TBL] [Abstract][Full Text] [Related]
34. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
35. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
[TBL] [Abstract][Full Text] [Related]
36. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
37. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
[TBL] [Abstract][Full Text] [Related]
38. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
[TBL] [Abstract][Full Text] [Related]
39. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer.
Keller SM; Vangel MG; Wagner H; Schiller J; Herskovic A; Komaki R; Gray R; Marks RS; Perry MC; Livingston RB; Johnson DH;
Lung Cancer; 2003 Oct; 42(1):79-86. PubMed ID: 14512191
[TBL] [Abstract][Full Text] [Related]
40. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
Komiya T; Chaaya G; Powell E
Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
